Allyson J. Ocean's most recent trade in NovoCure Ltd was a trade of 16,697 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Allyson J. Ocean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 16,697 | 16,697 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Allyson J. Ocean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 11,215 | 14,269 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Allyson J. Ocean | Director | Sale of securities on an exchange or to another person at price $ 17.29 per share. | 03 Jun 2025 | 999 | 3,054 (0%) | 0% | 17.3 | 17,269 | Ordinary Shares |
| NovoCure Ltd | Allyson J. Ocean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 6,229 | 6,229 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | Allyson J. Ocean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 4,053 | 4,053 | - | 0 | Restricted Stock Units |